NEW YORK, October 2 (Reuters) -Eli Lilly was asked to produce more insulin; Pfizer to produce more of its top-selling cancer drug Ibrance and its cholesterol drug Lipitor; and London-based AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback